Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB2 | P05107 | 5/20 | 0.48 |
| ▸ | ICAM1 | P05362 | 5/20 | 0.48 |
| ▸ | ITGAL | P20701 | 5/20 | 0.48 |
| ▸ | MCHR1 | Q99705 | 4/20 | 0.39 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.37 |
| ▸ | BACE1 | P56817 | 5/20 | 0.36 |
| ▸ | CTSD | P07339 | 1/20 | 0.36 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.36 |
| ▸ | PSD | A5PKW4 | 1/20 | 0.36 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.35 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13817292 | 0.84 | ITGB2 (0.70) | ITGB2ICAM1ITGAL | |
| SCHEMBL13823838 | 0.79 | ITGAL (0.51) | ITGB2ICAM1ITGAL | |
| SCHEMBL13817170 | 0.74 | ITGB2 (0.77) | ITGB2ICAM1ITGAL | |
| SCHEMBL4238659 | 0.73 | ITGB2 (0.72) | ITGB2ICAM1ITGAL | |
| SCHEMBL13816995 | 0.70 | ITGB2 (0.73) | ITGB2ICAM1ITGAL | |
| SCHEMBL13817154 | 0.68 | ITGB2 (0.79) | ITGB2ICAM1ITGAL | |
| SCHEMBL7672836 | 0.65 | MCHR1 (0.38) | ITGB2ICAM1ITGALMCHR1CYP11B1 | |
| SCHEMBL14019343 | 0.65 | ITGB2 (0.81) | ITGB2ICAM1ITGAL | |
| SCHEMBL13817322 | 0.65 | ITGB2 (0.80) | ITGB2ICAM1ITGAL | |
| SCHEMBL4018223 | 0.65 | ITGB2 (1.00) | ITGB2ICAM1ITGAL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7550494-B2 | Small molecules useful in the treatment of inflammatory disease | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2009-06-23 | — | — | US | disclosed |